BK Virus Infection: Clinical Trials

6 trials for BK Virus Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed, 1 terminated, 1 unknown. 6 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 16Recruiting 2, Completed 1, Terminated 1, Unknown 1, Withdrawn 1

Follow BK Virus Infection: new trials by email Literature Review of BK Virus Infection trials Research Report on BK Virus Infection

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
Rapidly generated virus specific T (R-MVST) cells - Epstein-Barr Virus, Cytomegalovirus Infections
Phase 1RecruitingMonica Bhatia182025-04-202026-07-30
Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients
Virus-specific Cytotoxic T-lymphocytes - Adenovirus Infection, BK Virus Infection
Phase 1TerminatedM.D. Anderson Cancer Center122023-01-062026-08-11
R-MVST Cells for Treatment of Viral Infections
Rapidly generated virus specific T (R-MVST) cells - Epstein-Barr Virus Infections, Cytomegalovirus Infections
Phase 1RecruitingColumbia University362022-05-032026-06-10
BK With VST for Kidney Transplant Patients
BK-specific T cells from Donor Lymphocytes - Kidney Transplant Infection, BK Virus Infection
Phase 1CompletedUniversity of Wisconsin, Madison32021-12-162024-12-10
Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient
BD03 - Cytomegalovirus Infections, Preventation of Cytomegalovirus Reactivation
Phase 1UnknownSL VAXiGEN182018-04-272018-07-03
Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)
Viralym-B - BK Virus Infection
Phase 1WithdrawnAlloVir2018-03-012018-04-09

Narrower conditions

Cytomegalovirus Infections (4)  ·  Adenoviridae Infections (3)  ·  Epstein-Barr Virus Infections (2)  ·  Hematologic Neoplasms (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Virus Diseases (1)

Broader conditions

Infections (5)  ·  DNA Virus Infections (4)  ·  Herpesviridae Infections (4)  ·  Virus Diseases (4)  ·  Tumor Virus Infections (2)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)

Interventions

Cell Count (2)

Sponsors

AlloVir (1)  ·  Columbia University (1)  ·  M.D. Anderson Cancer Center (1)  ·  Monica Bhatia (1)  ·  SL VAXiGEN (1)  ·  University of Wisconsin, Madison (1)

Countries

United States (5)  ·  South Korea (1)

Top investigators

Bilal Omer, MD (1)  ·  Jacques Galipeau, MD (1)  ·  May Daher, MD (1)  ·  Monica Bhatia, MD (1)  ·  Pawel Muranski, MD (1)  ·  Sandesh Parajuli, MD (1)  ·  Swati Naik, MD (1)

Results publications

PMID 40249038